Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.145
-0.065 (-2.02%)
At close: Dec 20, 2024, 4:00 PM
3.150
+0.005 (0.16%)
After-hours: Dec 20, 2024, 6:49 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $33.92 million as of December 20, 2024. Its market cap has decreased by -17.01% in one year.
Market Cap
33.92M
Enterprise Value
6.16M
1-Year Change
-17.01%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $33.92M, an increase of 11.83%. That is a compound annual growth rate of 2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 33.92M | -27.09% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 35.87M |
| NEXGEL | 35.56M |
| Surrozen | 34.33M |
| Elevation Oncology | 34.29M |
| Outlook Therapeutics | 34.06M |
| Marker Therapeutics | 33.91M |
| Nexalin Technology | 33.83M |
| BioVie | 33.71M |